IBB vs LQD
iShares Biotechnology ETF vs iShares iBoxx Investment Grade Corporate Bond ETF
- • LQD has the lower expense ratio at 0.14% vs 0.44% for IBB.
- • LQD pays a higher dividend yield (4.55%).
Side-by-side metrics
| Metric | IBB | LQD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.14% |
Dividend yield Trailing 12-month yield. | 0.23% | 4.55% |
AUM Assets under management — bigger funds are typically more liquid. | $7.95B | $30.92B |
YTD return | 3.10% | 0.60% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.74 | 1.34 |
P/E ratio | 23.72 | 32.88 |
Last price | $170.10 | $108.74 |
Inception | — | — |
Issuer | iShares | iShares |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
LQD top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 0.76% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About LQD
LQD (iShares iBoxx Investment Grade Corporate Bond ETF) is US investment-grade corporate bonds. Managed by iShares, the fund carries $30.9B in assets under management, an expense ratio of 0.14%, a dividend yield of 4.55%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 0.8% of the portfolio.